EGFR and glioblastoma: This study, using patient‐derived GBM cells and GBM cell lines, demonstrates that EGFR‐mediated activation of ERK signaling is necessary for YTHDF2 stabilization, which leads to m6A‐dependent mRNA decay of the nuclear receptor LXRα resulting in reduced intracellular cholesterol availability.